In this article, we have compared four human monoclonal antibodies specific to alternatively-spliced components of the extracellular matrix and have identified F8 as a suitable candidate for pharmacodelivery applications in rheumatoid arthritis. Here, F8 is linked to rheumatoid arthritis.